New hope for early detection of stomach cancer

March 17, 2014 by Robyn Mills

(Medical Xpress)—University of Adelaide research has provided new hope for the early detection of stomach cancer with the identification of four new biomarkers in the blood of human cancer patients.

Stomach or gastric cancer is the fourth most common cancer in the world and the second leading cause of death due to cancer.

"Stomach cancer is typically without symptoms in the early stages so most cancers are not diagnosed until the later stages, and the survival rates are therefore low," says Associate Professor Peter Hoffmann, project leader and Director of the University's Adelaide Proteomics Centre.

"Endoscopic investigations are invasive and expensive and most are generally not conducted until the cancer is at an advanced stage.

"A non-invasive, inexpensive screening technique through a simple blood test for the of stomach cancer would make a huge difference in the survival outcomes for people with this disease."

Published in the journal Biochimica et Biophysica Acta, the researchers have identified four new proteins that change in concentration in the blood of stomach cancer patients.

In this latest research, conducted by Dr Julia Humphries who is now at SA Pathology and Dr Megan Penno, they showed differences in the four protein levels between serum samples from 37 patients, including 11 early stage , and the controls which included healthy and non-cancerous patients with other gastric disease.

All four proteins - afamin, clusterin, haptoglobin and vitamin D binding protein (VDBP) - were individually superior to a current clinical marker CA72-4 in discriminating stomach cancer from healthy controls.

"Using the four markers together produces high levels of selectivity and sensitivity in detecting ," says Associate Professor Hoffmann.

Explore further: Study reveals optimal interval for stomach cancer screening

More information: Julia M. Humphries, Megan A.S. Penno, Florian Weiland, Manuela Klingler-Hoffmann, Agnieszka Zuber, Alex Boussioutas, Matthias Ernst, Peter Hoffmann, "Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer," Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Available online 7 February 2014, ISSN 1570-9639,

Related Stories

Study reveals optimal interval for stomach cancer screening

July 16, 2012

A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the ...

Scientists discover how stomach cancer spreads

November 13, 2012

Scientists at the University of Liverpool have found that the production of a protein that prevents the growth and spread of cancerous cells is impaired in patients with gastric cancer.

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.